Kitabis pak and Calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kitabis pak (tobramycin) and Calcium (calcium). Common drug interactions include discomfort among females and pseudomonas infection among males.

The phase IV clinical study analyzes what interactions people have when they take Kitabis pak and Calcium. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Kitabis pak?

Kitabis pak has active ingredients of tobramycin. eHealthMe is studying from 921 Kitabis pak users. Check the latest studies of Kitabis pak.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.



On Aug, 01, 2026

18 people who take Kitabis pak and Calcium together, and have interactions are studied.

Kitabis pak and Calcium drug interactions.

What are the common drug interactions of Kitabis Pak and Calcium, by gender? *:

female:

  1. Discomfort
  2. Ear infection
  3. Fungal infection
  4. Pneumonia
  5. Pulmonary congestion (congestion in the lungs)
  6. Sinusitis (inflammation of sinus)
  7. Urinary tract infection
  8. Weight increased
  9. Alanine aminotransferase increased
  10. Aspartate aminotransferase increased

male:

  1. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypersomnia (excessive daytime sleepiness (eds))
  4. Increased bronchial secretion
  5. Infective exacerbation of bronchiectasis (severe infective lung disease)
  6. Pain
  7. Wheezing (a high-pitched whistling sound made while you breath)
  8. Hospitalisation
  9. Infection
  10. Parainfluenzae virus infection

What are the common drug interactions of Kitabis Pak and Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Death

10-19:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Rhinovirus infection
  3. Alanine aminotransferase increased
  4. Aspartate aminotransferase increased
  5. Blood alkaline phosphatase increased
  6. Weight increased
  7. Hospitalisation
  8. Infection
  9. Parainfluenzae virus infection
  10. Pulmonary function test decreased

20-29:

  1. Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
  2. Pulmonary function test decreased
  3. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  4. Infective exacerbation of bronchiectasis (severe infective lung disease)
  5. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  6. Pain

30-39:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Renal disorder (kidney disease)

40-49:

n/a

50-59:

n/a

60+:

  1. Ageusia (loss of taste functions of the tongue)
  2. Lung transplant
  3. Weight decreased
  4. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 14 people, 77.78%
  2. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 11.11%
  3. Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 11.11%
  4. Lung Disorder (lung disease): 1 person, 5.56%
  5. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 5.56%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.56%
  7. Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 1 person, 5.56%
  8. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 5.56%
  9. Asthma: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Kitabis pak and Calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kitabis pak and Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kitabis pak:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kitabis pak and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin and calcium (the active ingredients of Kitabis pak and Calcium, respectively), and Kitabis pak and Calcium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: